Schroder Investment Management Group’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-26,141
Closed -$161K 1264
2019
Q1
$161K Buy
26,141
+2,815
+12% +$32.6K ﹤0.01% 1080
2018
Q4
$269 Sell
23,326
-4,985
-18% -$85K ﹤0.01% 1058
2018
Q3
$613K Sell
28,311
-5,694
-17% -$108K ﹤0.01% 1002
2018
Q2
$547K Buy
34,005
+12,138
+56% +$191K ﹤0.01% 1034
2018
Q1
$412K Sell
21,867
-8,652
-28% -$171K ﹤0.01% 1082
2017
Q4
$531K Buy
+30,519
New +$421K ﹤0.01% 1087

Other funds holding ARA

Schroder Investment Management Group's ARA Position: Q2 2019 in Review

Schroder Investment Management Group sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2019, closing a stake of 26,141 shares — an estimated $161K sold.

Schroder Investment Management Group first reported a position in ARA in Q4 2017 and held it in 6 quarters. The position peaked at $613K in Q3 2018. 67 funds tracked by Wall St. Rank hold ARA as of Q2 2019.

  • Schroder Investment Management Group reported no remaining American Renal Associates Holdings, Inc position as of Q2 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 26,141 American Renal Associates Holdings, Inc shares in Q2 2019, an estimated $161K.
  • Schroder Investment Management Group first reported a position in American Renal Associates Holdings, Inc in Q4 2017 and held it in 6 quarters.
  • Schroder Investment Management Group's American Renal Associates Holdings, Inc position peaked at $613K in Q3 2018.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2019.

Based on Schroder Investment Management Group's 13F filing for Q2 2019, filed 8 Aug 2019.